Innate Pharma S.A. (OTCMKTS:IPHYF – Get Free Report) was the target of a large growth in short interest in the month of September. As of September 30th, there was short interest totalling 6,000 shares, a growth of 22.4% from the September 15th total of 4,900 shares. Based on an average daily trading volume, of 600 shares, the short-interest ratio is presently 10.0 days.
Innate Pharma Stock Performance
Shares of IPHYF stock remained flat at $2.25 during midday trading on Tuesday. The firm has a 50 day moving average of $2.22 and a 200 day moving average of $2.29. Innate Pharma has a 12-month low of $1.93 and a 12-month high of $2.90.
About Innate Pharma
Further Reading
- Five stocks we like better than Innate Pharma
- Trading Stocks: RSI and Why it’s Useful
- Goldman Sachs Earnings Reveal Market Moves Investors Can’t Ignore
- Business Services Stocks Investing
- AMD Gains Momentum With AI: Can It Beat Expectations?
- What is the Euro STOXX 50 Index?
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets
Receive News & Ratings for Innate Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innate Pharma and related companies with MarketBeat.com's FREE daily email newsletter.